- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 251/32 - Oximes
Patent holdings for IPC class C07C 251/32
Total number of patents in this class: 30
10-year publication summary
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ambrx, Inc. | 181 |
7 |
| University of Southampton | 446 |
2 |
| BASF SE | 21080 |
1 |
| The Regents of the University of California | 20230 |
1 |
| AstraZeneca AB | 2857 |
1 |
| AstraZeneca UK Limited | 610 |
1 |
| Syngenta Crop Protection AG | 6232 |
1 |
| Shin-Etsu Chemical Co., Ltd. | 5745 |
1 |
| Advansix Resins & Chemicals LLC | 303 |
1 |
| Cognis IP Management GmbH | 619 |
1 |
| GE Healthcare Limited | 660 |
1 |
| Guangzhou Magpie Pharmaceutical Co., Ltd | 1 |
1 |
| Kyung Nong Corporation | 15 |
1 |
| Oak Ridge National Laboratory | 3 |
1 |
| Screen Holdings Co., Ltd. | 2914 |
1 |
| Universidad de Leon | 26 |
1 |
| Universidad Publica de Navarra | 50 |
1 |
| The University of Melbourne | 544 |
1 |
| University of Tennessee Research Foundation | 754 |
1 |
| University of Virginia Patent Foundation | 1598 |
1 |
| Other owners | 3 |